HIGHLIGHTS
- who: Nancy A. Sherman from the Post Approval Clinical Development, Pfizer Inc, East, nd Street, Office, New York, NY, USA have published the article: The Midazolam RAMPART Study Medical Records Project: A Unique Use of Real-World Data in a Complex Collaborative Partnership to Support a New Drug Application, in the Journal: (JOURNAL)
- what: The aim of this midazolam RAMPART medical records project (MRP) was to retrospectively obtain and review the medical records of all RAMPART participants to comprehensively identify and extract safety and other clinical data, including renal and hepatic events, into an analyzable . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.